OMX Copenhagen 20
1.811,66
PKT
+2,35
PKT
+0,13
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.08.19 | A.P. Moeller - Maersk A-S (B) neutral | Morgan Stanley | |
06.08.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
05.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
31.07.19 | Novo Nordisk buy | UBS AG | |
08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
08.07.19 | Novo Nordisk Hold | Deutsche Bank AG | |
08.07.19 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
28.06.19 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
20.06.19 | Novo Nordisk Hold | Deutsche Bank AG | |
18.06.19 | Novo Nordisk buy | UBS AG | |
17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |
14.06.19 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
13.06.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.06.19 | Novo Nordisk Outperform | Credit Suisse Group | |
11.06.19 | Novo Nordisk buy | UBS AG | |
11.06.19 | Novo Nordisk Equal weight | Barclays Capital | |
11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
30.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.05.19 | Novo Nordisk Reduce | HSBC | |
28.05.19 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
28.05.19 | A.P. Moeller - Maersk A-S (B) verkaufen | Barclays Capital | |
28.05.19 | Novo Nordisk Reduce | HSBC | |
24.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
17.05.19 | A.P. Moeller - Maersk A-S (B) kaufen | Credit Suisse Group | |
17.05.19 | Novo Nordisk Underweight | Barclays Capital | |
07.05.19 | Novo Nordisk buy | UBS AG | |
07.05.19 | Novo Nordisk Neutral | Oddo BHF | |
07.05.19 | Novo Nordisk Reduce | HSBC | |
06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. |